tradingkey.logo

Pacific Biosciences of California Inc

PACB
1.820USD
+0.105+6.12%
종가 02/06, 16:00ET시세는 15분 지연됩니다
549.37M시가총액
손실P/E TTM

Pacific Biosciences of California Inc

1.820
+0.105+6.12%

자세한 내용은 Pacific Biosciences of California Inc 회사

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Pacific Biosciences of California Inc 정보

종목 코드 PACB
회사 이름Pacific Biosciences of California Inc
상장일Oct 27, 2010
CEOHenry (Christian O)
직원 수575
유형Ordinary Share
회계 연도 종료Oct 27
주소1305 O'brien Drive
도시MENLO PARK
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94025
전화16505218000
웹사이트https://www.pacb.com/
종목 코드 PACB
상장일Oct 27, 2010
CEOHenry (Christian O)

Pacific Biosciences of California Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-152571.00%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-22821.00%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-22821.00%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
+22821.00%
Mr. Bill Ericson ,J.D.
Mr. Bill Ericson ,J.D.
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-22821.00%
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-152571.00%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-22821.00%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-22821.00%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
+22821.00%
Mr. Bill Ericson ,J.D.
Mr. Bill Ericson ,J.D.
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-22821.00%

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Consumable revenue
21.28M
55.35%
Instrument revenue
11.32M
29.44%
Service And Other
5.84M
15.20%
지역별USD
이름
수익
비율
North America
18.10M
47.08%
Europe (including the Middle East and Africa)
10.75M
27.97%
Asia Pacific
9.59M
24.95%
사업별
지역별
사업별USD
이름
수익
비율
Consumable revenue
21.28M
55.35%
Instrument revenue
11.32M
29.44%
Service And Other
5.84M
15.20%

주식 보유 통계

마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
ARK Investment Management LLC
12.34%
SoftBank Group Corp
6.77%
BlackRock Institutional Trust Company, N.A.
6.58%
The Vanguard Group, Inc.
5.64%
Edmond de Rothschild Asset Management (France) S.A.
3.54%
기타
65.12%
주주
주주
비율
ARK Investment Management LLC
12.34%
SoftBank Group Corp
6.77%
BlackRock Institutional Trust Company, N.A.
6.58%
The Vanguard Group, Inc.
5.64%
Edmond de Rothschild Asset Management (France) S.A.
3.54%
기타
65.12%
주주 유형
주주
비율
Investment Advisor
40.49%
Investment Advisor/Hedge Fund
10.60%
Holding Company
6.77%
Hedge Fund
3.14%
Individual Investor
1.16%
Corporation
1.16%
Research Firm
1.13%
Sovereign Wealth Fund
0.40%
Bank and Trust
0.14%
기타
35.01%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
547
169.14M
56.02%
-65.44M
2025Q3
566
166.98M
55.32%
-97.69M
2025Q2
600
214.62M
71.52%
-110.62M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
ARK Investment Management LLC
30.92M
10.24%
-5.37M
-14.81%
Sep 30, 2025
SoftBank Group Corp
20.45M
6.77%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
19.86M
6.58%
-103.12K
-0.52%
Sep 30, 2025
The Vanguard Group, Inc.
16.38M
5.43%
+362.80K
+2.27%
Sep 30, 2025
Edmond de Rothschild Asset Management (France) S.A.
10.68M
3.54%
-2.69M
-20.13%
Sep 30, 2025
Amova Asset Management Co., Ltd.
8.68M
2.87%
-540.90K
-5.87%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.91M
2.29%
+187.78K
+2.79%
Sep 30, 2025
State Street Investment Management (US)
5.91M
1.96%
+155.06K
+2.69%
Sep 30, 2025
Madrone Advisors, LLC
4.98M
1.65%
-11.79M
-70.31%
Sep 30, 2025
Millennium Management LLC
4.92M
1.63%
+4.05M
+466.29%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
ARK Genomic Revolution ETF
2.3%
iShares Genomics Immunology and Healthcare ETF
1.31%
Invesco NASDAQ Future Gen 200 ETF
0.96%
Global X Genomics & Biotechnology ETF
0.69%
ARK Innovation ETF
0.58%
AXS Green Alpha ETF
0.58%
WisdomTree BioRevolution Fund
0.48%
Invesco RAFI US 1500 Small-Mid ETF
0.09%
ProShares Ultra Nasdaq Biotechnology
0.08%
Invesco Nasdaq Biotechnology ETF
0.07%
더 보기
ARK Genomic Revolution ETF
비율2.3%
iShares Genomics Immunology and Healthcare ETF
비율1.31%
Invesco NASDAQ Future Gen 200 ETF
비율0.96%
Global X Genomics & Biotechnology ETF
비율0.69%
ARK Innovation ETF
비율0.58%
AXS Green Alpha ETF
비율0.58%
WisdomTree BioRevolution Fund
비율0.48%
Invesco RAFI US 1500 Small-Mid ETF
비율0.09%
ProShares Ultra Nasdaq Biotechnology
비율0.08%
Invesco Nasdaq Biotechnology ETF
비율0.07%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI